HIV prevention: antibodies and vaccine development

HIV prevention: antibodies and vaccine development

Despite 40 years of research the HIV epidemic remains a significant global health challenge and an HIV vaccine is still elusive. The recent results from the AMP trial have shown that a broadly neutralizing antibody can provide protection from infection.

Evento virtuale
Quando: 
26/07/2021 - da 15:00 a 17:00
Personale di riferimento: